Yahoo
Oslo - Delayed Quote NOK

Borregaard ASA (BRG.OL)

153.80 -3.60 (-2.29%)
At close: October 30 at 4:26:32 PM GMT+1
Chart Range Bar
Loading chart for BRG.OL
  • Previous Close 157.40
  • Open 158.40
  • Bid 154.20 x 391200
  • Ask 154.60 x 721000
  • Day's Range 154.00 - 159.40
  • 52 Week Range 137.60 - 200.50
  • Volume 89,055
  • Avg. Volume 85,930
  • Market Cap (intraday) 15.325B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 55.93
  • EPS (TTM) 2.75
  • Earnings Date Oct 28, 2026
  • Forward Dividend & Yield 4.75 (3.09%)
  • Ex-Dividend Date Apr 17, 2026
  • 1y Target Est 175.60

Borregaard ASA engages in the development, production, and marketing of specialized biochemicals and biomaterials in Norway, rest of Europe, Asia, the United States, and internationally. It operates in three segments: BioSolutions, BioMaterials, and Fine Chemicals. The BioSolutions segment develops, produces, and sells biopolymers and biovanillin derived from lignin for agrochemicals, batteries, industrial binders, and construction, as well as to flavor and fragrance companies, and food and beverage industry. Its BioMaterials segment develops, produces, and sells speciality cellulose used as a raw material in the production of cellulose ethers, cellulose acetate, and other specialty products, as well as cellulose fibrils for industrial applications. The Fine Chemicals segment supplies fine chemical intermediates for contrast agents and advanced bioethanol. The company was incorporated in 2012 and is headquartered in Sarpsborg, Norway.

www.borregaard.com

1,193

Full Time Employees

December 31

Fiscal Year Ends

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .

YTD Return

BRG.OL
20.71%
MSCI WORLD (^990100-USD-STRD)
9.06%

1-Year Return

BRG.OL
15.90%
MSCI WORLD (^990100-USD-STRD)
9.89%

3-Year Return

BRG.OL
9.82%
MSCI WORLD (^990100-USD-STRD)
0.00%

5-Year Return

BRG.OL
15.41%
MSCI WORLD (^990100-USD-STRD)
53.16%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY26
Revenue 1.89B
Earnings 295M
Profit Margin 15.58%

Q4

FY25

Q1

FY26

Q2

FY26

Q3

FY26

0
500M
1B
2B
2B
-5.0%
0.0%
5.0%
10.0%
15.0%

Analyst Insights

View More

Analyst Price Targets

148.00
175.60 Average
153.80 Current
190.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    3.43%

  • Return on Assets (ttm)

    7.97%

  • Return on Equity (ttm)

    4.32%

  • Revenue (ttm)

    7.85B

  • Net Income Avi to Common (ttm)

    269M

  • Diluted EPS (ttm)

    2.75

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    360M

  • Total Debt/Equity (mrq)

    36.37%

  • Levered Free Cash Flow (ttm)

    326.5M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: